Wednesday, June 17, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1051 of 1,261
  1. US 7427394

    Biodegradable poly(β-amino esters) and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  2. US 7427630

    Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

    Neurocrine Biosciences, Inc. · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  3. US 7425644

    Method of purifying pravastatin

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Sep 16, 2008 · Expires Sep 11, 2028

    granted
  4. US 7425611

    Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 16, 2008 · Expires Sep 11, 2028

    granted
  5. US 7425218

    Nitric oxide-releasing medical devices

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 16, 2008 · Expires Sep 11, 2028

    granted
  6. US 7425329

    Methods for treating bone cancer pain by administering a nerve growth factor antagonist

    Regents of the University of Minnesota · Granted Sep 16, 2008 · Expires Sep 11, 2028

    granted
  7. US 7425449

    Site specific Listeria integration vectors and methods for using the same

    The Regents of the University of California · Granted Sep 16, 2008 · Expires Sep 11, 2028

    granted
  8. US 7423118

    IAPS associated cell cycle proteins, compositions and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  9. US 7423066

    Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism

    The Regents of the University of California · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  10. US 7422755

    Antimultiorganism glycoconjugate vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  11. US 7423159

    Agent for preventing or treating neuropathy

    Takeda Pharmaceutical Company Limited · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  12. US 7423142

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Pharmaceuticals, Inc. · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  13. US 7422738

    Combined cancer treatment methods using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  14. US 7422867

    Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

    Rigel Pharmaceuticals, Inc. · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  15. US 7423015

    Antihelminthic drugs as a treatment for hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  16. US 7423043

    4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  17. US 7422900

    System and method for forming a connective tissue construct

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  18. US 7423049

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  19. US 7419962

    3,6-bicyclolides

    Enanta Pharmaceuticals, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  20. US 7419983

    Gonadotropin-releasing hormone receptor antagonists and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  21. US 7420030

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  22. US 7420100

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  23. US 7420084

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  24. US 7420045

    IAPs associated cell cycle proteins, compositions and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.